Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Nu Skin (NUS) is benefiting from effective product launches. However, the company is battling challenges stemming from the spread of the delta variant across several markets.

Nu Skin's (NUS) Solid Innovations Aid, Pandemic-Led Hurdles Hurt

Nu Skin (NUS) expects Q3 revenues in the band of $637-$642 million, lower than the previous range. Challenges caused by the delta variant across several markets are a downside.

Nu Skin (NUS) Lowers Q3 Revenue View Amid Pandemic-Led Hurdles

G-III Apparel Group

Hibbett Sports

MetLife

Mosaic

ArcelorMittal

Signet Jewelers

Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like SIG, GIII, NUS, MET, MT, MOS and HIBB are promising picks.

7 Low Price-to-Sales Stocks for Value-Focused Investors

Nu Skin Enterprises Inc (NYSE: NUS) expects third-quarter revenue of $637 million -$642 million (consensus $710.11 million), down from the previous guidance of $700 million - $730 million. Nu Skin noted unanticipated government restrictions had impacted its ability to sell and distribute products, with the largest impact in Mainland China and Southeast Asia.

Nu Skin Cuts Q3 Revenue Outlook As Delta Variant Disrupts Sales

Shares of Nu Skin Enterprises Inc. NUS, +2.50% dropped 3.6% toward a 15-month low in premarket trading Monday, after the personal care products company warned of a revenue miss, saying the delta variant has led to unexpected COVID-related disruptions. The company said it estimates third-quarter revenue of $637 million to $642 million, below the FactSet consensus of $710 million.

Nu Skin stock drops toward 15-month low after warning of revenue miss

PROVO, Utah, Oct. 4, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced estimated third quarter revenue between $637 and $642 million. "Our third quarter revenue was softer than anticipated as the delta variant created unexpected disruptions in many of our markets," said Ryan Napierski, president and CEO of Nu Skin.

Nu Skin Enterprises Provides Estimated Third Quarter Revenue

NUS is exposed to an attractive market and is now resorting to social commerce with greater fervor to attract more clients.

Nu Skin: Key Themes

Yamana Gold

Meritor

V.F.

Vertex Pharmaceuticals

These stocks are disconnected from their earnings outlook as the analysts remain bullish but the Street is bearish.

5 Top Ranked Stocks on Sale Right Now

Bristol-Myers

Ironwood Pharma

The Baby Boomers are getting older, which means investors should consider adding undervalued healthcare stocks to their portfolio. The post 3 Cheap Healthcare Stocks to Buy Right Now appeared first on InvestorPlace.

3 Cheap Healthcare Stocks to Buy Right Now

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Nu Skin Enterprises (NUS) is a Top-Ranked Value Stock: Should You Buy?

Foot Locker

Piper Sandler Cos

Standard Motor Products

Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, GIII, NUS, MET, PIPR, HIBB, and SMP are promising picks.

7 Low Price-to-Sales Stocks to Buy in the Current Market

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?

Why Is Nu Skin (NUS) Down 8.2% Since Last Earnings Report?

KB Home

Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, MT, NUS, MET, PIPR, KBH, and SMP are promising picks.

Scoop Up These 7 Low Price-to-Sales Stocks Reflecting Strength

Bassett Furniture

Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like HIBB, BSET, NUS, MET, MT, KBH, and SMP are promising picks.

7 Low Price-to-Sales Stocks to Replenish Your Portfolio

Nu Skin's (NUS) second-quarter 2021 earnings and revenues increase year over year on growth in sales leaders. Also, management raises 2021 earnings view.

Nu Skin (NUS) Q2 Earnings Beat Estimates, Sales Grow Y/Y

Nu Skin Enterprises, Inc.'s (NUS) CEO Ritch Wood on Q2 2021 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 8.49% and 0.21%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Q2 Earnings and Revenues Beat Estimates

PROVO, Utah, Aug. 4, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second-quarter 2021 revenue of $704.1 million and earnings per share (EPS) of $1.15 driven by an increase in operating margin of 260 basis points. Executive Summary Q2 2021 vs.

Nu Skin Enterprises Reports 42 Percent EPS Growth And 15 Percent Revenue Growth In The Second Quarter

Nu Skin's (NUS) second-quarter 2021 performance is likely to reflect gains from the company's efforts to strengthen sales leader and expand customer. Also, online strength has been a driver.

Nu Skin (NUS) Queued for Q2 Earnings: Key Things to Note

Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nu Skin Enterprises (NUS) Earnings Expected to Grow: Should You Buy?

Nu Skin Enterprises (NUS) has been struggling lately, but the selling pressure may be coming to an end soon

Nu Skin (NUS) Sees Hammer Chart Pattern: Time to Buy?

Nu Skin Enterprises Inc (NYSE: NUS) subsidiary Grōv Technologies has signed an agreement with California-based Superior Farms for 10 Olympus Tower Farms to produce fresh year-round feed for Superior's upcoming Sheep Discovery Center in Central Utah. Under the agreement, the ten farms will produce 60,000 pounds of Grōv's High-Density Nutrient Super feed wheatgrass a day using less than 5% of the water, without pesticides or herbicides.

Nu Skin Subsidiary Signs Agreement With Superior Farms

VINEYARD, Utah, July 12, 2021 /PRNewswire/ -- Agtech and indoor farming company, Grōv Technologies, today announced a definitive agreement with California-based Superior Farms for the purchase of 10 Olympus Tower Farms that will produce fresh year-round feed for Superior's upcoming Sheep Discovery Center™ in Central Utah. Grōv is part of Superior Farms' efforts to dramatically improve the sustainability and growth of U.S. lamb production.

Grōv Technologies Signs Definitive Agreement with Superior Farms to Bring Sustainability to Ground-breaking U.S. Lamb Production

Quanex Building Products

Sonoco Products

Toronto-Dominion Bank

Weingarten Realty

The crux of safe investment lies in choosing a company that is not overburdened with debt as a debt-free stock is almost impossible to find. You may buy NUS, SON, NX, WRI and TD.

Buy These 5 Low Leverage Stocks to Keep Debt Risks Away

PROVO, Utah, July 7, 2021 /PRNewswire/ -- Nu Skin (NYSE: NUS) is hosting its annual Force for Good Day as part of its commitment to humanitarian efforts both locally and globally. It is a day set aside for Nu Skin brand affiliates, employees and their families to participate in local service projects focused on benefiting the lives of thousands of at-risk children around the globe.

News for Nu Skin Enterprises Stock (NUS)